Document Detail

A review of focal therapy techniques in prostate cancer: clinical results for high-intensity focused ultrasound and focal cryoablation.
MedLine Citation:
PMID:  22232569     Owner:  NLM     Status:  PubMed-not-MEDLINE    
The advancement of focal therapy technology for the treatment of prostate cancer (PCa) is emerging as an option for a middle ground between radical therapies and active surveillance for individuals identified with localized, low-grade PCa. Two promising techniques are high-intensity focused ultrasound (HIFU) and focal cryoablation. Both focal cryoablation and HIFU show promise, but additional prospective trials are necessary before any definitive conclusions can be made on either method's viability.
Colin T Iberti; Nihal Mohamed; Michael A Palese
Related Documents :
19685529 - Cost-effectiveness analysis of immediate radical cystectomy versus intravesical bacillu...
21592649 - New therapies for castration-resistant prostate cancer: efficacy and safety.
21790219 - An alternative approach to study the changes in the cancer pattern of men in india (198...
19536899 - Key concerns about the current state of bladder cancer: a position paper from the bladd...
15582259 - Expression analysis and potential functional role of the cxcr4 chemokine receptor in bl...
19666349 - Management of lower urinary tract dysfunction after radical hysterectomy with or withou...
11863389 - The fireside hypothesis: was there differential selection to tolerate air pollution dur...
18786719 - Multidisciplinary panel discussion of a gynecologic oncology patient: preventing wound ...
20537379 - Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of me...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Reviews in urology     Volume:  13     ISSN:  1523-6161     ISO Abbreviation:  Rev Urol     Publication Date:  2011  
Date Detail:
Created Date:  2012-01-10     Completed Date:  2012-05-08     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  100889067     Medline TA:  Rev Urol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e196-202     Citation Subset:  -    
Department of Urology, The Mount Sinai Hospital, Mount Sinai School of Medicine New York, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Review of the literature: PCA3 for prostate cancer risk assessment and prognostication.
Next Document:  Benign paratesticular fibrous pseudotumor with malignant clinical features.